DIAGAST
Jean-Francois Petit is an experienced sales and business development professional with a strong track record in the biotechnology and software industries. Currently serving as Sales Director at DIAGAST since August 2024, Jean-Francois previously held the position of Directeur Commercial - CCO at BYG INFORMATIQUE SAS from September 2019 to September 2024. Prior roles include Business Development Director at Sterience and various leadership positions at Abbott, LabVantage Solutions, and Applied Biosystems, focusing on strategic account management and sales team leadership. Jean-Francois's career began with Dendrite and HEXAFLUX, specializing in CRM solutions and software for medical analysis laboratories, respectively. Jean-Francois holds a Maitrise in Biologie et Biochimie from ESBB (Ecole Supérieure de Biologie et de Biochimie), completed in 1997.
This person is not in any teams
DIAGAST
1 followers
Receiving blood is receiving life. DIAGAST’s goal is to help healthcare professionals transmit life with the help of the best blood group determination technologies. Even though it is not always a matter of life and death, transfusion errors are never acceptable. Over the last 30 years, DIAGAST has developed unparalleled expertise and know-how in the transfusion sector. DIAGAST develops, manufactures and markets reagents (for blood group determination), miniaturized laboratories for manual analysis and automated systems. DIAGAST also ensures the research, manufacturing and marketing of all its products. Moreover, DIAGAST offers a wide range of related services, such as a training center for their automated systems, a hotline and on-site follow-up on automaton calibration. We even make control and measurement tools available over the Internet. DIAGAST is now the worldwide leader in the marketing and development of reagents and instrumentation systems that aim to ensure donor and patient compatibility during blood transfusions.